ClinicalTrials.Veeva

Menu

Occipital Nerve Stimulation in Fibromyalgia

A

Antwerp University Hospital (UZA)

Status and phase

Completed
Phase 2

Conditions

Fibromyalgia

Treatments

Device: Occipital nerve stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT00917176
FMS_ONS_01

Details and patient eligibility

About

The aim of this study is to investigate whether greater occipital nerve stimulation is effective in the treatment of fibromyalgia related pain. The study uses sub sensory threshold stimulation and placebo stimulation in order to investigate whether sub-threshold stimulation is feasible in a placebo controlled study.

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed according to the criteria of the American College of Rheumatology (ACR-90)
  • Minimally treated with adequate trials during 3 months
  • Insight of the patient in her disease and capable of understanding and signing an informed consent

Exclusion criteria

  • History of severe illness or suffering from severe chronic disease
  • History of substance abuse, unless treated and in remission during 6 months
  • Cardiac disease
  • History of epileptic insults
  • Psychiatric disorders with psychotic symptoms
  • Pace maker / defibrillator
  • Pregnancy

Trial design

0 participants in 2 patient groups, including a placebo group

Effective stimulation
Experimental group
Description:
Effective stimulation at sub-threshold level
Treatment:
Device: Occipital nerve stimulation
Placebo stimulation
Placebo Comparator group
Description:
Stimulation at non-effective strength
Treatment:
Device: Occipital nerve stimulation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems